InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,433.74
(
0.23%
)
US TECH 100
19,089.60
(
0.65%
)
Dow Jones
38,647.10
(
-0.17%
)
Brent Oil
82.15
(
0.21%
)
Bitcoin
66,672.95
(
-0.13%
)
Post# of 285919
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

SSP

Send PM Follow Ignore
Followers 643
Posts 44677
Boards Moderated 3
Alias Born 08/02/2000

SSP

Member Level

Re: None

Monday, 03/31/2014 3:21:12 PM

Monday, March 31, 2014 3:21:12 PM

Post# of 285919
AVNR - AVP-825, I can't see this being rejected by the FDA, just check out how it works,

Play the video; http://www.optinose.com/products/powder-delivery-device

OptiNose licensed exclusive North American rights for the further development and commercialization of AVP-825 to Avanir Pharmaceuticals in July 2013. In accordance with this arrangement, OptiNose will ultimately transfer the U.S. IND for AVP-825 to Avanir, and Avanir assumed responsibility for the final filing of the U.S. NDA and for North American commercial manufacturing and sales.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up